Therefore, to understand the clonal structure, proliferative, and differentiation capacity of neoplastic cells in the hematologic neoplasm, and identification of loss‐of‐function variants in TET2 is crucial. Here, TET2 is linked to hematopoietic and lymphoid system neoplasm.